Literature DB >> 15569399

Troponin I, cardiac diastolic dysfunction and restrictive cardiomyopathy.

Xu-pei Huang1, Jian-feng Du.   

Abstract

Cardiomyopathies are diseases of heart muscle that are associated with cardiac dysfunction. Molecular genetic studies performed to date have demonstrated that the damage or mutations in several sarcomeric contractile protein genes are associated with the development of the diseases. In this review, cardiac troponin I, one of the sarcomeric thin filament protein, will be discussed regarding its role in cardiac function, its deficiency-related diastolic dysfunction, and the mutation of this protein-mediated restrictive cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569399

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  10 in total

1.  No correlation between the p38 MAPK pathway and the contractile dysfunction in diabetic cardiomyocytes: hyperglycaemia-induced signalling and contractile function.

Authors:  Sibylle Wenzel; Golozar Soltanpour; Klaus-Dieter Schlüter
Journal:  Pflugers Arch       Date:  2005-07-23       Impact factor: 3.657

Review 2.  Cardiac troponin mutations and restrictive cardiomyopathy.

Authors:  Michelle S Parvatiyar; Jose Renato Pinto; David Dweck; James D Potter
Journal:  J Biomed Biotechnol       Date:  2010-06-08

3.  Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI.

Authors:  Jianfeng Du; Jing Liu; Han-Zhong Feng; M M Hossain; Nariman Gobara; Chi Zhang; Yuejin Li; Pierre-Yves Jean-Charles; Jian-Ping Jin; Xu-Pei Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-11       Impact factor: 4.733

4.  Predicting cardiomyopathic phenotypes by altering Ca2+ affinity of cardiac troponin C.

Authors:  Michelle S Parvatiyar; Jose Renato Pinto; Jingsheng Liang; James D Potter
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

5.  Application of echocardiography on transgenic mice with cardiomyopathies.

Authors:  G Chen; Y Li; J Tian; L Zhang; P Jean-Charles; N Gobara; C Nan; J-P Jin; X P Huang
Journal:  Biochem Res Int       Date:  2012-05-21

6.  Insights into restrictive cardiomyopathy from clinical and animal studies.

Authors:  Pierre-Yves Jean-Charles; Yue-Jin Li; Chang-Long Nan; Xu-Pei Huang
Journal:  J Geriatr Cardiol       Date:  2011-09       Impact factor: 3.327

Review 7.  The cell biology of disease: cellular mechanisms of cardiomyopathy.

Authors:  Pamela A Harvey; Leslie A Leinwand
Journal:  J Cell Biol       Date:  2011-08-08       Impact factor: 10.539

8.  Characterization of aging-associated cardiac diastolic dysfunction.

Authors:  Wei-Ting Chang; Jung-San Chen; Yung-Kung Hung; Wei-Chuan Tsai; Jer-Nan Juang; Ping-Yen Liu
Journal:  PLoS One       Date:  2014-05-28       Impact factor: 3.240

9.  Nodal signalling in Xenopus: the role of Xnr5 in left/right asymmetry and heart development.

Authors:  Emmanuel Tadjuidje; Matthew Kofron; Adnan Mir; Christopher Wylie; Janet Heasman; Sang-Wook Cha
Journal:  Open Biol       Date:  2016-08       Impact factor: 6.411

10.  Role of Whole-exome Sequencing in Phenotype Classification and Clinical Treatment of Pediatric Restrictive Cardiomyopathy.

Authors:  Wen-Hong Ding; Ling Han; Yan-Yan Xiao; Ying Mo; Jing Yang; Xiao-Fang Wang; Mei Jin
Journal:  Chin Med J (Engl)       Date:  2017-12-05       Impact factor: 2.628

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.